par Piccart-Gebhart, Martine ;Speyer, J L;Wernz, J C;Noumoff, J;Beller, U;Beckman, M;Dubin, N;Demopoulos, R;Muggia, F
Référence European journal of cancer & clinical oncology, 23, 6, page (631-641)
Publication Publié, 1987-06
Référence European journal of cancer & clinical oncology, 23, 6, page (631-641)
Publication Publié, 1987-06
Article révisé par les pairs
Titre: |
|
Auteur: | Piccart-Gebhart, Martine; Speyer, J L; Wernz, J C; Noumoff, J; Beller, U; Beckman, M; Dubin, N; Demopoulos, R; Muggia, F |
Informations sur la publication: | European journal of cancer & clinical oncology, 23, 6, page (631-641) |
Statut de publication: | Publié, 1987-06 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antineoplastic Combined Chemotherapy Protocols -- therapeutic use |
Cisplatin -- administration & dosage | |
Cisplatin -- adverse effects | |
Combined Modality Therapy | |
Cyclophosphamide -- administration & dosage | |
Cyclophosphamide -- adverse effects | |
Drug Evaluation | |
Female | |
Humans | |
Middle Aged | |
Ovarian Neoplasms -- drug therapy | |
Ovarian Neoplasms -- mortality | |
Ovarian Neoplasms -- surgery | |
Reoperation | |
Time Factors | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Research Support, U.S. Gov't, P.H.S. | |
Langue: | Anglais |
Identificateurs: | urn:issn:0277-5379 |
info:pmid/3653186 |